← FDA DRUG APPROVALS
FDA ANDA · ANDA077620
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Sponsor: SUN PHARM INDS INC
APPLICATION
ANDA077620
TYPE
ANDA
ORIGINAL APPROVAL
2008-01-11
LATEST ACTION
2017-04-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
GLIPIZIDE AND METFORMIN HYDROCHLORIDEDiscontinued
GLIPIZIDE 2.5MG, METFORMIN HYDROCHLORIDE 500MG · TABLET · ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDEDiscontinued
GLIPIZIDE 5MG, METFORMIN HYDROCHLORIDE 500MG · TABLET · ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDEDiscontinued
GLIPIZIDE 2.5MG, METFORMIN HYDROCHLORIDE 250MG · TABLET · ORAL
Approval history
2017-04-05Labeling · Supplement 13 · standardAP
2015-09-21Labeling · Supplement 11 · standardAP
2009-03-11Labeling · Supplement 3AP
2009-02-03Labeling · Supplement 2AP
2008-01-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.